BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30894313)

  • 41. Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid.
    Hata M; Koike I; Omura M; Maegawa J; Ogino I; Inoue T
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):605-11. PubMed ID: 21300468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mohs micrographic excision of sebaceous carcinoma of the eyelids.
    Yount AB; Bylund D; Pratt SG; Greenway HT
    J Dermatol Surg Oncol; 1994 Aug; 20(8):523-9. PubMed ID: 8056887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment.
    Buitrago W; Joseph AK
    Dermatol Ther; 2008; 21(6):459-66. PubMed ID: 19076624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved Margin Control of Microcystic Adnexal Carcinoma After Mohs Micrographic Surgery Compared With Wide Local Excision.
    Yerneni S; Murad F; Schmults CD; Ruiz ES
    Dermatol Surg; 2023 Apr; 49(4):317-321. PubMed ID: 36716422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sebaceous carcinoma: an updated review of pathogenesis, diagnosis, and treatment options.
    Dowell-Esquivel C; Lee R; DiCaprio RC; Nouri K
    Arch Dermatol Res; 2023 Dec; 316(1):55. PubMed ID: 38112896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
    Català A; Garces JR; Alegre M; Gich IJ; Puig L
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
    Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
    J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eyelid sebaceous gland carcinoma (SGC) treated with 'slow' Mohs' micrographic surgery.
    Arora A; Barlow RJ; Williamson JM; Olver JM
    Eye (Lond); 2004 Aug; 18(8):854-5. PubMed ID: 14976544
    [No Abstract]   [Full Text] [Related]  

  • 49. Utility of Intraoperative Cytokeratin-7 Immunostaining During Mohs Micrographic Surgery for Sebaceous Carcinoma.
    Crum OM; Steen AJ; Demer AM; Vidal NY
    Dermatol Surg; 2024 Apr; 50(4):384-386. PubMed ID: 38261738
    [No Abstract]   [Full Text] [Related]  

  • 50. Sebaceous Carcinoma Treated With Mohs Micrographic Surgery.
    Brady KL; Hurst EA
    Dermatol Surg; 2017 Feb; 43(2):281-286. PubMed ID: 28165350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological features of patients with wide local excision of eyelid malignant neoplasms: a more than five years retrospective study from China.
    Han Y; Kong M; Luo Y; Sun B; Wang Z; Zhang H
    BMC Ophthalmol; 2022 Nov; 22(1):436. PubMed ID: 36376823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Collision tumor of sebaceous carcinoma and squamous cell carcinoma of the eyelid: Case report.
    Wang JJ; Lee KF; Chen CY
    Eur J Ophthalmol; 2022 Sep; 32(5):NP55-NP59. PubMed ID: 34011202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sebaceous cell carcinoma of the eyelid: a rapidly enlarging lesion with massive xanthogranulomatous inflammation.
    Hwang FS; Neekhra A; Lucarelli MJ; Warner TF; Snow SN; Albert DM
    Ophthalmic Plast Reconstr Surg; 2010; 26(3):208-10. PubMed ID: 20489549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.
    Tolkachjov SN; Kelley BF; Alahdab F; Erwin PJ; Brewer JD
    J Am Acad Dermatol; 2018 Nov; 79(5):929-934.e6. PubMed ID: 29981390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sebaceous carcinoma of the eyelid - different diagnostic times, different outcomes: case reports.
    Vianna LM; Cariello AJ; Lowen MS; Sant'Anna AE; Hofling-Lima AL
    Arq Bras Oftalmol; 2011; 74(6):444-6. PubMed ID: 22331120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes.
    Song A; Carter KD; Syed NA; Song J; Nerad JA
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):194-200. PubMed ID: 18520834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sebaceous carcinoma of the eyelid--two case reports].
    Zieliński T; Antoszewski B
    Klin Oczna; 2014; 116(2):127-9. PubMed ID: 25345292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sebaceous carcinoma of the periorbital and extraorbital regions.
    Pickford MA; Hogg FJ; Fallowfield ME; Webster MH
    Br J Plast Surg; 1995 Mar; 48(2):93-6. PubMed ID: 7743054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wide local excision vs. Mohs Tübingen technique in the treatment of dermatofibrosarcoma protuberans: a two-centre retrospective study and literature review.
    Veronese F; Boggio P; Tiberio R; Gattoni M; Fava P; Caliendo V; Colombo E; Savoia P
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2069-2076. PubMed ID: 28573714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.